KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $22.6 million.

  • Chemed's Change in Account Payables rose 1598098.59% to $22.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.5 million, marking a year-over-year increase of 25533.63%. This contributed to the annual value of -$9.3 million for FY2024, which is 73.81% up from last year.
  • Latest data reveals that Chemed reported Change in Account Payables of $22.6 million as of Q3 2025, which was up 1598098.59% from $10.1 million recorded in Q2 2025.
  • Chemed's Change in Account Payables' 5-year high stood at $32.7 million during Q2 2023, with a 5-year trough of -$43.0 million in Q1 2024.
  • Its 5-year average for Change in Account Payables is $876315.8, with a median of $6.5 million in 2023.
  • As far as peak fluctuations go, Chemed's Change in Account Payables plummeted by 39596.89% in 2023, and later skyrocketed by 1598098.59% in 2025.
  • Chemed's Change in Account Payables (Quarter) stood at $3.5 million in 2021, then skyrocketed by 788.29% to $31.1 million in 2022, then crashed by 79.21% to $6.5 million in 2023, then soared by 60.23% to $10.4 million in 2024, then skyrocketed by 117.63% to $22.6 million in 2025.
  • Its Change in Account Payables was $22.6 million in Q3 2025, compared to $10.1 million in Q2 2025 and -$22.6 million in Q1 2025.